Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Title: Enhanced Fungal Inhibition with High-Dose Rose Bengal Photodynamic Antimiocrobial Therapy
Author Affiliations & Notes
  • Salomon Merikansky
    Ophthalmic Biophysics Center, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Heather Ann Durkee
    Ophthalmic Biophysics Center, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Juan Carlos Navia
    Ophthalmic Biophysics Center, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Felipe Echeverri Tribin
    Ophthalmic Biophysics Center, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Katherine Krishna
    Ophthalmic Biophysics Center, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Anam Ahmed
    Ophthalmic Biophysics Center, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Alex Gonzalez
    Ophthalmic Biophysics Center, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Cornelis Rowaan
    Ophthalmic Biophysics Center, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Harry W. Flynn
    Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
    Ophthalmic Biophysics Center, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Jean-Marie A Parel
    Ophthalmic Biophysics Center, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
    Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Darlene Miller
    Ocular Microbiology Laboratory, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
    Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Guillermo Amescua
    Ophthalmic Biophysics Center, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
    Ophthalmology, University of Miami Health System Bascom Palmer Eye Institute, Miami, Florida, United States
  • Footnotes
    Commercial Relationships   Salomon Merikansky None; Heather Durkee University of Miami; US20230218923A1, Code P (Patent); Juan Carlos Navia None; Felipe Echeverri Tribin None; Katherine Krishna None; Anam Ahmed None; Alex Gonzalez University of Miami, US20230218923A1, Code P (Patent); Cornelis Rowaan University of Miami, US20230218923A1, Code P (Patent); Harry Flynn None; Jean-Marie Parel University of Miami, US20230218923A1, Code P (Patent); Darlene Miller University of Miami, US20230218923A1, Code P (Patent); Guillermo Amescua University of Miami, US20230218923A1, Code P (Patent)
  • Footnotes
    Support  This work was financially supported in part by the Beauty of Sight Foundation, the Edward D. and Janet K. Robson Foundation, NIH Center Grant (P30EY14801), Research to Prevent Blindness – Unrestricted Grant to BPEI (GR004596), the Henri and Flore Lesieur Foundation (JMP), and donations from Drs. Harry W. Flynn Jr, Karl R. Olsen, Martha E. HildebranSSdt. We thank Maribel Hernandez for her technical support.
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 4128. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Salomon Merikansky, Heather Ann Durkee, Juan Carlos Navia, Felipe Echeverri Tribin, Katherine Krishna, Anam Ahmed, Alex Gonzalez, Cornelis Rowaan, Harry W. Flynn, Jean-Marie A Parel, Darlene Miller, Guillermo Amescua; Title: Enhanced Fungal Inhibition with High-Dose Rose Bengal Photodynamic Antimiocrobial Therapy. Invest. Ophthalmol. Vis. Sci. 2024;65(7):4128.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Fungal keratitis, primarily caused by Aspergillus and Fusarium species, is the leading cause of unilateral blindness worldwide. When first-line treatments like polyenes and azoles fail, alternative approaches are needed. One such therapy is rose bengal (RB) photodynamic antimicrobial therapy (PDAT) which uses a dye activated by green light to generate antimicrobial singlet oxygen. Aspergillus and Curvularia species are resistant to the standard clinical dose of RB PDAT (0.1% RB, 5.4 J/cm2) and we hypothesize that increasing the RB concentration and light energy will increase the antifungal inhibition.

Methods : Four clinical isolates (Aspergillus glaucus (n =1), Aspergillus fumigatus (n = 1), and Curvularia species (n = 2)) were isolated and prepared in NaCl for a final concentration of 1x10E4. RB was prepared at 3 concentrations (0.1, 0.2, 0.5%) in NaCl. Organisms were mixed with either NaCl (control) or each concentration of RB, and plated in 1mL aliquots onto SabDex agar in triplicate. Plates were further separated into three groups based on light intensity (6, 12, 18 mW) and irradiated with a custom-made LED green (518nm) light for 15 minutes. A control group with no irradiation was per in all four species. At 72 hours, agar plates were photographed to evaluate fungal growth inside of a centered 47-mm irradiation zone.

Results : Growth inhibition to RB PDAT was strain dependent with A. fumigatus showing slightly greater inhibition to RB PDAT than A. glaucus. Inhibition zones for A. fumigatus were highest in the 0.5%RB, 18 mW condition with a small central clearing (~8mm). Both Curvularia species showed less inhibition to RB PDAT with some clearing but no clear inhibition zone. Increasing the concentration and light energy increased the growth inhibition, but not completely.

Conclusions : Growth inhibition to high concentration RB-PDAT was strain dependent; with greater inhibition in the high concentration RB groups, rather than the high fluence groups. However, these results must be considered together as higher RB levels have more light absorption, potentially limiting efficacy in deeper corneal layers. Balancing these factors, the combination of High concentration/High Fluence is likely the most efficacious for these recalcitrant fungal species. Nonetheless, further safety studies are crucial to assess the potential impacts of increased RB and green light exposure on the cornea.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×